Arup Kumar Mandal

Arup Kumar Mandal

Auto-generated profile, based on publicly available information

Arup Kumar Mandal

Department of Urology, All India Institute of Medical Sciences, Rishikesh, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Journal of Endourology
Verified
Journal Article
Closed access
ATAbhishek Thakur
Abhishek Thakur
ASAditya P. Sharma
Aditya P. Sharma
SDSudheer Kumar Devana
Sudheer Kumar Devana
KPKalpesh Mahesh Parmar
Kalpesh Mahesh Parmar
RMRavimohan S. Mavuduru
Ravimohan S. Mavuduru
AMArup Kumar Mandal
Arup Kumar Mandal
Introduction: Miniaturization of percutaneous nephrolithotomy (mPCNL) was proposed to decrease postoperative bleeding, as there is decreased parenchymal injury compared with standard percutaneous nephrolithotomy (SPCNL). Published randomized controlled trials (RCTs) evaluating bleeding after mPCNL have shown conflicting results. Hence, the evidence to say that mPCNL offers less postoperative bleeding is not robust. Materials and Methods: Prospective RCT was done by comparing mPCNL and SPCNL for treatment of renal stones of size 1 to 3 cm. Patients with active urinary tract infection, renal malformation, uncorrected coagulopathy, and raised serum creatinine (>1.5 mg/dL) were excluded. Blood loss was evaluated by measuring fall in hemoglobin and hematocrit on postoperative day 1. Postoperative pain was evaluated by visual analogue scale (VAS) score at 6, 24, and 48 hours. Results: A total of 60 patients (30 in each arm) were enrolled during the study period. All the baseline preoperative variables were comparable in both the groups. The SPCNL group had a significantly higher drop in hematocrit level as compared with mPCNL (4.6 ± 3.1% vs 3.1 ± 2.1%, p = 0.02). The mean fall in hemoglobin was higher in SPCNL as compared with mPCNL (1.61 ± 0.9 gm% vs 1.21 ± 0.7 gm%, p = 0.07), but it was not significant. Blood transfusion (BT) rate was comparable in both the groups (one patient in each group). The mPCNL group had significantly less VAS scores at 6 hours (3.27 ± 1.20 vs 4.40 ± 1.52, p = 0.002) and 24 hours (2.10 ± 0.54 vs 2.83 ± 1.05, p = 0.001) after surgery. Postoperative complications and hospital stay were comparable in both the arms. Conclusion: mPCNL is associated with less postoperative bleeding and pain than SPCNL. However, the small tract size does not prevent against the clinically significant bleeding requiring BT.

23 March 2016 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
KBK. Bishnoi
K. Bishnoi
GBGirdhar Singh Bora
Girdhar Singh Bora
RMR. S. Mavuduru
R. S. Mavuduru
SDS. K. Devana
S. K. Devana
SSS. K. Singh
S. K. Singh
AMA. K. Mandal
A. K. Mandal

1 August 2021 in Urology
Verified
Journal Article
Closed access
TNTushar Aditya Narain
Tushar Aditya Narain
JTJyoti Mohan Tosh
Jyoti Mohan Tosh
GGGagan Gautam
Gagan Gautam
HTHarkirat Singh Talwar
Harkirat Singh Talwar
VPVikas Kumar Panwar
Vikas Kumar Panwar
AMArup Kumar Mandal
Arup Kumar Mandal

13 December 2022 in Current Urology
Verified
Journal Article
Open access
SRSatish Kumar Ranjan
Satish Kumar Ranjan
AMAnkur Mittal
Ankur Mittal
AMAnissa Atif Mirza
Anissa Atif Mirza
SKSunil Kumar
Sunil Kumar
VPVikas Kumar Panwar
Vikas Kumar Panwar
KMKim Jacob Mammen
Kim Jacob Mammen
Background: Nephrolithiasis is a global health problem. The recurrence rate after the first stone clearance is approximately 50% at 5 years. Metabolic abnormalities are an important factor responsible for stone recurrence. Our prevalidated study aimed to evaluate metabolic abnormalities associated with first-time uncomplicated renal stone formers (FTURSF). Materials and methods: In this prospective, exploratory, time-bound, descriptive study, 30 first-time renal stone formers were evaluated for metabolic abnormalities. High-risk stone formers were excluded from the study. Data were collected in a predefined proforma, transferred to an Excel sheet, and analyzed using the Statistical Package for Social Sciences 20 and Epi Info 7. Fisher exact test, Mann-Whitney U test, paired t test, and Pearson correlation coefficient were used for statistical analyses. Results: The mean age of the participants was 35.57 ± 11.07 years, with a male-to-female ratio of 1.72. The most common abnormality was a 24-hour urine volume of <2.5 L in 73.33% of the participants. One or more metabolic abnormalities were detected in 76.67% of the participants. Other common metabolic abnormalities detected were hypocitraturia (60%), hypercalciuria (16.67%), hyperoxaluria (13.33%), and hyperuricosuria (3.33%). Parathyroid adenoma was detected in one participant (3.33%). Conclusions: Our study documented significant metabolic abnormalities in FTURSF. Therefore, a simplified metabolic evaluation protocol should be adopted while evaluating FTURSF. Detection of an underlying metabolic abnormality would enable the early institution of preventive measures to reduce stone recurrence and related complications.

18 August 2021 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
AKA. Krishnan
A. Krishnan
GSGopal Sharma
Gopal Sharma
SDS. K. Devana
S. K. Devana
DZD. Zohmangaihi
D. Zohmangaihi
RMR. S. Mavuduru
R. S. Mavuduru
GBGirdhar Singh Bora
Girdhar Singh Bora

1 January 2025 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
AMAnkur Mittal
Ankur Mittal
GSGurpremjit Singh
Gurpremjit Singh
VPVikas Kumar Panwar
Vikas Kumar Panwar
DKDeepak Kumar
Deepak Kumar
OAOmang Agarwal
Omang Agarwal
AMArup K. Mandal
Arup K. Mandal
Mittal A, et al. Investig Clin Urol. 2025 Nov;66(6):491-500. https://doi.org/10.4111/icu.20240399